https://www.selleckchem.com/pr....oducts/nec-1s-7-cl-o
we may have been underpowered to detect differences in these secondary endpoints. Future large, multisite studies may be needed to address these conflicting results more definitively. LEVEL OF EVIDENCE Level III, therapeutic study.OBJECTIVES We examined data from the International Registry of the Extracorporeal Life Support Organization to identify risk factors for mortality in pregnant and peripartum patients receiving extracorporeal membrane oxygenation. DESIGN Retrospective analysis. SETTING International Registry of Extra
Like
Comment
Share
